Minneapolis, MN, United States of America

Natalya Goloviznina

This inventor holds 1 USPTO granted patent. Top assignee: Regents of the University of Minnesota. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Natalya Goloviznina. Retrieved from https://idiyas.com/inventor/natalya-goloviznina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Natalya Goloviznina: Innovator in Cell Production Methods

Introduction

Natalya Goloviznina is a prominent inventor based in Minneapolis, MN (US). She has made significant contributions to the field of cell biology, particularly in the production of fibroadipogenic progenitor cells. Her innovative methods have the potential to advance research in regenerative medicine and tissue engineering.

Latest Patents

Goloviznina holds a patent titled "Methods for producing fibroadipogenic progenitor cells." This patent outlines methods for producing a preparation of fibroadipogenic progenitors (FAPs) from a cell mixture. In certain embodiments, the patent describes a method of producing a preparation of human FAPs from a skeletal muscle biopsy sample for later use. This work is crucial for developing therapies that utilize these progenitor cells.

Career Highlights

Natalya Goloviznina is affiliated with the University of Minnesota, where she conducts her research. Her work has garnered attention for its innovative approach to cell production, which could have far-reaching implications in medical science.

Collaborations

She has collaborated with notable colleagues, including Michael Kyba and Ning Xie, who share her commitment to advancing research in cell biology and regenerative medicine.

Conclusion

Natalya Goloviznina's contributions to the field of cell production are noteworthy, and her patent reflects her innovative spirit. Her work at the University of Minnesota continues to inspire advancements in regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…